Nombre del producto:(+/-)-Narwedine

IUPAC Name:(1S,12S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-one

CAS:1668-86-6
Fórmula molecular:C17H19NO3
Pureza:95%
Número de catálogo:CM244272
Peso molecular:285.34

Unidad de embalaje Stock disponible Precio($) Cantidad
CM244272-250mg in stock řř
CM244272-1g in stock ĜĨƏ
CM244272-5g in stock řƩĜ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1668-86-6
Fórmula molecular:C17H19NO3
Punto de fusión:-
Código de sonrisas:O=C1C=C[C@@]23CCN(C)CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24
Densidad:
Número de catálogo:CM244272
Peso molecular:285.34
Punto de ebullición:
Nº Mdl:MFCD13193038
Almacenamiento:

Column Infos

ZUNVEYL
Alpha Cognition announced that the FDA has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer’s disease. ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine, the important brain neurotransmitter involved in memory, motivation, and attention functions. The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer’s disease as it is only the second oral AD treatment to be approved in more than a decade.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products